3D printing and bioprinting in medicine

How medical 3D printing works

Medical 3D printing starts with a digital model, often built from a patient's own CT or MRI scans. Software converts the anatomy into a precise blueprint, and a printer then builds the object layer upon layer using materials such as medical-grade plastics, resins, metals like titanium, or ceramics. Because the design comes from the individual's scans, the result can match their exact anatomy — something mass production cannot do. Different printing methods suit different jobs: melting metal powder for strong implants, curing liquid resin for fine detail, or extruding softer materials for models. This ability to make one-off, complex, personalised shapes affordably is what makes the technology so useful in medicine.

Devices, implants and surgical planning

The most established medical uses are already in NHS practice. Custom implants and prosthetics — such as titanium plates shaped to rebuild part of a skull, jaw or joint — fit better and can improve outcomes. Dentistry uses printing routinely for crowns, bridges and aligners, and hearing aids are widely printed to fit each ear. Surgeons increasingly use anatomical models printed from a patient's scans to plan and rehearse complex operations, and patient-specific surgical guides help place cuts or screws accurately. Printing can also create bespoke splints, prosthetic limbs and assistive devices at lower cost. These applications shorten operating time, improve fit and help clinicians explain procedures clearly to patients.

What bioprinting adds

Bioprinting is 3D printing that uses living cells suspended in a supportive gel, known as bioink, instead of plastic or metal. The aim is to build structures that mimic real tissue, complete with the right cell types arranged in the right pattern. A major challenge is keeping cells alive and creating the tiny blood vessels that thicker tissues need to receive oxygen and nutrients. Today, bioprinting is mostly a research and laboratory tool rather than a routine treatment. Scientists print small samples of skin, cartilage and other tissues to study disease, test drugs and reduce reliance on animal experiments. Simpler tissues are closer to real-world use than complex, solid organs.

Realistic progress and future promise

It is important to separate genuine progress from hype. Printed skin grafts, cartilage repair and bone-like scaffolds that encourage the body to regrow tissue are advancing through research and early trials. Bioprinted tissue models are already helping pharmaceutical scientists test new medicines more accurately. The long-term dream — printing whole, transplantable organs such as kidneys or hearts to solve donor shortages — remains years to decades away, because organs are extraordinarily complex and must be fully connected to a blood supply. Realistic near-term wins are smaller: better implants, personalised drug-release devices, tissue patches and powerful laboratory models. Steady, careful advances, not overnight breakthroughs, are how this field is maturing.

Safety, regulation and challenges

Because these products go into or onto the body, safety and regulation are central. In the UK, medical devices — including many 3D-printed implants — are regulated by the Medicines and Healthcare products Regulatory Agency, and must meet strict standards for materials, sterility and performance. Personalised, point-of-care printing inside hospitals raises new questions about quality control, consistency and responsibility that regulators are actively addressing. Bioprinted living tissues face additional hurdles around sourcing cells, proving long-term safety, and rigorous clinical trials before any routine use. Cost, access and the need for specialist skills also shape how quickly benefits reach patients. Careful oversight ensures innovation is matched by evidence that these technologies are safe and effective.